Table 2.
Transcranial Magnetic Stimulation Measures of the Contralesional Side in the 2 Treatment Groupsa
| Experimental | Control | |
|---|---|---|
| rMT 1 | 52.06 ± 3.16 | 47.38 ± 3.48 |
| rMT 2 | 51.31 ± 2.69 | 47.23 ± 3.41 |
| rMT 3 | 52.44 ± 2.52 | 49.10 ± 4.46 |
| aMT 1 | 45.28 ± 3.72 | 36.69 ± 3.23 |
| aMT 2 | 42.00 ± 2.90 | 37.69 ± 3.20 |
| aMT 3 | 45.69 ± 3.02 | 36.11 ± 3.04 |
| Motor map area 1 (cm2) | 4.87 ± 0.42 | 4.39 ± 0.43 |
| Motor map area 2 (cm2) | 5.42 ± 0.54 | 5.49 ± 0.71 |
| Motor map area 3 (cm2) | 4.62 ± 0.63 | 4.83 ± 0.97 |
| COGx 1 | 4.70 ± 0.27 | 4.37 ± 0.22 |
| COGx 2 | 4.58 ± 0.24 | 4.16 ± 0.31 |
| COGx 3 | 4.65 ± 0.28 | 3.87 ± 0.34 |
| COGy 1 | 2.76 ± 0.57 | 3.43 ± 0.46 |
| COGy 2 | 2.95 ± 0.57 | 3.44 ± 0.40 |
| COGy 3 | 2.62 ± 0.54 | 3.37 ± 0.64 |
a
Resting motor threshold (rMT), active motor threshold (aMT), transcranial magnetic stimulation (TMS) motor map area, and centers of gravity for the x-coordinate (COGx) and y-coordinate (COGy) collected in the extensor digitorum communis muscle of the less-affected forearm at baseline (1), after 2 weeks (2), and at 4-month follow-up (3). Data are expressed as mean ± standard error.